Announcement of Nominees for Prix Galien Russia 2014 Awards
MOSCOW, RUSSIA, October 6, 2014 /EINPresswire.com/ -- The organizers of Prix Galien Russia today announced the official list of nominees2 for the Prix Galien Russia 2014 awards. Prix Galien is considered to be the biomedical industry’s highest honor to recognize scientific innovation for biopharmaceutical and medical technology products that improve the human condition.
This year’s ceremony will be held at the Pashkov House on October 23rd where the awards will be presented for this year’s five categories1. Divided into two main groups, Biopharmaceuticals and Medical Technology, Prix Galien Russia 2014 counts with 33 total candidates across the following categories: Research in Russia, Pharmaceutical Agent, Biotechnology Product, Russian Medical Technology, and Medical Technology.
The nominees for the Prix Galien Russia 2014 awards are:
Research in Russia (Nominees)
Radachlorin® RadaPharma
Dipeptide strategy in Pharmacology Zakusov Institute of Pharmacology
Diaskintest® CSJC “GENERIUM”
Study of bacteriophages asalternatives to antibiotics MIPT Life Science Center
Zoleren® PharmSintez
Pharmaceutical Agent (Nominees)
Bedaquiline (Sirturo®) Janssen
Dabigatran etexilate (Pradaxa®) Boehringer Ingelheim
Perampanel (Fycompa®) Eisai
Ethinylestradiol+drospirenone+levomefolate (Yaz Plus®) Bayer
Pasireotide (Signifor®) Novartis
Eribulin (Halaven®) Eisai
Rifaximin (AlfaNormix®) AlfaWassermann
Rivaroxaban (Xarelto®) Bayer
Ticagrelor (Brilinta®) Astra Zeneca
Tofacitinib (Jakvinus®) Pfizer
Biotechnology Product (Nominees)
Abtacept (ORENCIA®) Bristol-Myers Squibb
Adalimumab (Humira®) AbbVie
Canakinumab (Ilaris®) Novartis
Denosumab (Xgeva®) Amgen
Interferon beta-1a (Rebif®) Merck Serono
Palivizumab (Synagis®) AbbVie
Pneumococcal 13-valentConjugate Vaccine (Prevenar®) Pfizer
Ruxolitinib (Jakavi®) Novartis
Teriparatide (Forsteo®) Lilly
Ustekinumab (Stelara®) Janssen
Russsian Medical Technology (Nominees)
Amycard-01C Amycard
Microarrays Engelhardt Institute of Molecular Biology Russian Academy of Science
Orphagene® MIPT Life Science Center
ThrombodynamicsAnalyser System T-2 Hemacore
Laser-based analyzer of exhaled air The General Physics Instityte, named after Prokhorov
Medical Technology (Nominees)
Ultrasonic Dissection Device(Sonicision®) Covidien
Bioresorbable vascular scaffold(Absorb®) Abbott
HPV Test (Cobas 4800®) Roche Diagnostics
“Building on our achievements last year, we are glad to have successfully added Medical Technology categories to Prix Galien Russia and augmenting the Jury by bringing in relevant specialists in that domain”, remarked Frédéric Boucheseiche, General Secretary of the Prix Galien Russia. “With the support of our partners we continue to foster biomedical innovation in Russia and hope that Russian Galien laureates will soon be recognized internationally as well.”
About Prix Galien Russia:
Prix Galien Russia was inaugurated in Moscow in October 2013 under the auspice of an exceptional awards committee composed of eminent specialists involved in the sphere of Russian and international pharmaceutical research.
Around the world, Prix Galien rewards outstanding achievements in improving the global human condition through the development of innovative therapies.
To attend or support the Prix Galien Russia 2014 awards ceremony or for sponsorship opportunities, please contact: prixgalien@focusreports.net3
This year’s ceremony will be held at the Pashkov House on October 23rd where the awards will be presented for this year’s five categories1. Divided into two main groups, Biopharmaceuticals and Medical Technology, Prix Galien Russia 2014 counts with 33 total candidates across the following categories: Research in Russia, Pharmaceutical Agent, Biotechnology Product, Russian Medical Technology, and Medical Technology.
The nominees for the Prix Galien Russia 2014 awards are:
Research in Russia (Nominees)
Radachlorin® RadaPharma
Dipeptide strategy in Pharmacology Zakusov Institute of Pharmacology
Diaskintest® CSJC “GENERIUM”
Study of bacteriophages asalternatives to antibiotics MIPT Life Science Center
Zoleren® PharmSintez
Pharmaceutical Agent (Nominees)
Bedaquiline (Sirturo®) Janssen
Dabigatran etexilate (Pradaxa®) Boehringer Ingelheim
Perampanel (Fycompa®) Eisai
Ethinylestradiol+drospirenone+levomefolate (Yaz Plus®) Bayer
Pasireotide (Signifor®) Novartis
Eribulin (Halaven®) Eisai
Rifaximin (AlfaNormix®) AlfaWassermann
Rivaroxaban (Xarelto®) Bayer
Ticagrelor (Brilinta®) Astra Zeneca
Tofacitinib (Jakvinus®) Pfizer
Biotechnology Product (Nominees)
Abtacept (ORENCIA®) Bristol-Myers Squibb
Adalimumab (Humira®) AbbVie
Canakinumab (Ilaris®) Novartis
Denosumab (Xgeva®) Amgen
Interferon beta-1a (Rebif®) Merck Serono
Palivizumab (Synagis®) AbbVie
Pneumococcal 13-valentConjugate Vaccine (Prevenar®) Pfizer
Ruxolitinib (Jakavi®) Novartis
Teriparatide (Forsteo®) Lilly
Ustekinumab (Stelara®) Janssen
Russsian Medical Technology (Nominees)
Amycard-01C Amycard
Microarrays Engelhardt Institute of Molecular Biology Russian Academy of Science
Orphagene® MIPT Life Science Center
ThrombodynamicsAnalyser System T-2 Hemacore
Laser-based analyzer of exhaled air The General Physics Instityte, named after Prokhorov
Medical Technology (Nominees)
Ultrasonic Dissection Device(Sonicision®) Covidien
Bioresorbable vascular scaffold(Absorb®) Abbott
HPV Test (Cobas 4800®) Roche Diagnostics
“Building on our achievements last year, we are glad to have successfully added Medical Technology categories to Prix Galien Russia and augmenting the Jury by bringing in relevant specialists in that domain”, remarked Frédéric Boucheseiche, General Secretary of the Prix Galien Russia. “With the support of our partners we continue to foster biomedical innovation in Russia and hope that Russian Galien laureates will soon be recognized internationally as well.”
About Prix Galien Russia:
Prix Galien Russia was inaugurated in Moscow in October 2013 under the auspice of an exceptional awards committee composed of eminent specialists involved in the sphere of Russian and international pharmaceutical research.
Around the world, Prix Galien rewards outstanding achievements in improving the global human condition through the development of innovative therapies.
To attend or support the Prix Galien Russia 2014 awards ceremony or for sponsorship opportunities, please contact: prixgalien@focusreports.net3
Michael Comi
Focus Reports
+44 1707 828 754
email us here
1 http://prixgalienrussia.com/en/category/candidates-2014/
2 http://prixgalienrussia.com/en/category/candidates-2014/
3 http://prixgalien@focusreports.net